Fadrozole

Fadrozole
Clinical data

Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile
CAS Number	102676-47-1^Y hydrochloride: 102676-31-3^Y
PubChem CID	59693
ChemSpider	53850^N
UNII	H3988M64PU hydrochloride: H0Q44H4ECQ^Y
KEGG	D02451^Y
ChEMBL	CHEMBL9298^N
ECHA InfoCard	100.159.562
Chemical and physical data
Formula	C₁₄H₁₃N₃
Molar mass	223.27 g/mol
3D model (Jmol)	Interactive image
SMILES C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N
InChI InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2^N Key:CLPFFLWZZBQMAO-UHFFFAOYSA-N^N
^NY (what is this?)

Fadrozole (INN, marketed as Afema by Novartis) is a selectivearomatase inhibitor that has been introduced in Japan for the treatment of breast cancer.